Pharmacovigilance Blog

Literature Screening

Using the PICO Framework for Literature Screening in Pharmacovigilance

This guide explains how the PICO framework improves pharmacovigilance literature screening, helps build reproducible search strategies , & enables researchers.

Bala

Read

ICSR Management

Managing Pregnancy Reports in Pharmacovigilance: A Practical Guide

This practical guide explains how to track, assess, and process pregnancy reports, determine which cases qualify as ICSRs, reporting in E2B(R3),

Bala

Read

Drug safety and pharmacovigilance

The Consequences and Impact of Pharmacovigilance

Pharmacovigilance plays a vital role in protecting patients by identifying, assessing, & preventing from risks. Explore the impact of pharmacovigilance.

Bala

Read

MedDRA Series

MedDRA Encoding and Auto-Encoding: Key Considerations

This article explores the fundamentals of MedDRA encoding, the role of auto-encoding, & common pitfalls that every pharmacovigilance professional should understand.

Bala

Read

Drug safety and pharmacovigilance

E2B Cases: Classification, Differences, and Processing Explained

This blog features: Introduction If you work in a Drug Safety or Pharmacovigilance department, you have likely come…

Bala

Read

Public Authorities and Safety

Why VigiBase Matters: The Backbone of Global Pharmacovigilance

This article explores the structure, importance, statistics, & critical role of VigiBase in protecting public health through international PV collaboration.

Bala

Read

Public Authorities and Safety

SUGAM Portal: Complete Guide to CDSCO’s Online Regulatory System

This article provides a complete overview of the SUGAM portal, its purpose, major applications, key features, and its importance in India’s clinical ecosystem.

Bala

Read

ICSR Management

SAR vs SAE in Pharmacovigilance: Definitions, Differences, & Key Concepts

This article explains the definitions, highlights the critical differences between SAR and SAE, and explores the key concepts in pharmacovigilance.

Bala

Read